COMP <GO>
CL vs AMZN // REVENUE GROWTH (YOY)
Colgate-Palmolive Company (NYSE) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: CL 4
— AMZN 5
■ METRIC PARITY
LAST: $97.43 (+2.25%) • MKT CAP: $77.45B
revenue-growth
1.40%
LAST: $245.63 (+2.20%) • MKT CAP: $2.66T
revenue-growth
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CL VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CL | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 60.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 44.00% | 17.61% | +26.39 | CL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.5x | 16.1x | +3.38 | AMZN | /valuation <GO> |
| Free Cash Flow Yield | 4.42% | -1.77% | +6.19 | CL | /fcf-yield <GO> |
| Operating Margin | 16.20% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 10.50% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 1.40% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.90 | 3.38 | +3.52 | CL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | AMZN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.36% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.5 | 48.1 | +16.40 | CL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 1.46 | -0.35 | AMZN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.4x | 21.7x | +10.72 | AMZN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $77.45B | $2.66T | -$2.58T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CL REV | AMZN REV | CL GROSS % | AMZN GROSS % | CL FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $20.38B | $0 | 60.1% | — | $3.28B | $10.56B |
| FY 2024 | $20.10B | $0 | 60.5% | — | $3.20B | $42.95B |
| FY 2023 | $19.46B | $0 | — | — | $2.87B | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CL // BETA 1.11
AMZN // BETA 1.46